Sign in

CIK 0000875320

  • Large accelerated filer

VERTEX PHARMACEUTICALS INC / MA

Sign in to watch
Ticker
VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
043039129
Phone
+1 617-341-6393
Business address
50 NORTHERN AVENUE, BOSTON, MA, 02210
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$15,378,206
in 4 filings, $15.4M under 10b5-1 plans

Net −$15,378,206. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-06 ALTSHULER DAVID EVP, Global Research and CSO Exercise or conversion +1,304 $187.53 $245K 69,949
2023-02-06 ALTSHULER DAVID EVP, Global Research and CSO Sale −12 $300.39 $4K 69,937
2023-02-06 ALTSHULER DAVID EVP, Global Research and CSO Sale −70 $302.00 $21K 69,867
2023-02-06 ALTSHULER DAVID EVP, Global Research and CSO Sale −100 $303.64 $30K 69,767
2023-02-06 ALTSHULER DAVID EVP, Global Research and CSO Sale −349 $305.08 $106K 69,418
2023-02-06 ALTSHULER DAVID EVP, Global Research and CSO Sale −620 $306.70 $190K 68,798
2023-02-06 ALTSHULER DAVID EVP, Global Research and CSO Sale −153 $309.06 $47K 68,645
2023-02-06 ALTSHULER DAVID EVP, Global Research and CSO Exercise or conversion · Stock Option (Right to Buy) −1,304 0
2023-02-02 LEIDEN JEFFREY M Executive Chairman Shares withheld for taxes −3,578 $317.83 $1.1M 75,423
2023-02-01 WAGNER CHARLES F JR EVP & Chief Financial Officer Grant or award +10,324 53,188
2023-02-01 WAGNER CHARLES F JR EVP & Chief Financial Officer Grant or award +10,262 63,450
2023-02-01 WAGNER CHARLES F JR EVP & Chief Financial Officer Grant or award +9,440 72,890
2023-02-01 Tatsis Ourania EVP, Chief Reg. & Quality Off. Grant or award +6,194 52,284
2023-02-01 Tatsis Ourania EVP, Chief Reg. & Quality Off. Grant or award +10,262 62,546
2023-02-01 Tatsis Ourania EVP, Chief Reg. & Quality Off. Grant or award +7,866 70,412
2023-02-01 Sanna Bastiano EVP, Cell & Genetic Therapies Grant or award +9,092 47,090
2023-02-01 Sanna Bastiano EVP, Cell & Genetic Therapies Grant or award +12,314 59,404
2023-02-01 Sanna Bastiano EVP, Cell & Genetic Therapies Grant or award +7,866 67,270
2023-02-01 Sachdev Amit EVP, Chief Patient Officer Grant or award +10,324 63,676
2023-02-01 Sachdev Amit EVP, Chief Patient Officer Grant or award +8,210 71,886

Page 38 of 40 · 781 trades